The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the foreseeable future, due to surging demand for image-guided surgical procedures. Advancements in diagnostic imaging and growing number of diagnostic centers offering magnetic resonance imaging (MRI) services create a significant opportunity for players operating in the MRI contrast agents market.
Increasing investments in the magnetic resonance imaging contrast agents market by key market players and new product launches are major factors expected to boost growth further. The global magnetic resonance imaging contrast agents market was valued at US$ 871.0 Mn in 2021, and is expected to exhibit a CAGR of 4.4% during the forecast period (2022–2029).
Request a report sample to gain comprehensive insights at
|Data Points||Market Insights|
|Market Value 2022||U.S. $ 910.9 Mn|
|Market Value 2029||U.S. $ 1.23 Bn|
|Share of top 5 countries||60.8%|
|Key Players||The key players of the magnetic resonance imaging (MRI) contrast agents market are Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, and Miltenyi Biotec B.V. & Co. Kg.|
Key Takeaways of MRI Contrast Agents Market Study
- Extracellular fluid (ECF) agents contributed more than three-fourth value share of the magnetic resonance imaging contrast agents market in 2021. This can be attributed to the availability of more patient-compliant products, and better clinical outcomes due to their brief vascular phase, rapid distribution in the extracellular space, and faster elimination through renal systems than other contrast agents.
- Hospitals represented the highest market value share, followed by diagnostic centers, due to higher installed base of MRI units in hospitals and substantial visit to outpatient departments for the treatment and diagnosis of several disorders.
- North America holds the highest revenue share in the global magnetic resonance imaging contrast agents market, owing to significant number of MRI scans performed with contrast agents.
- Government initiatives towards the development of modern healthcare centers and financial support towards the growth of medical imaging technologies in Asian countries are expected to drive the growth of the magnetic resonance imaging contrast agents market in the region.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11023
New Product Launches – Imperative Strategy for Market Players
Increasing introduction of new MRI contrast agents is the major factor responsible for intense competition among market players. Several companies are focusing on launching new magnetic resonance imaging contrast agents to increase their product sales and expand market share. For example, in March 2017, GE Healthcare launched Clariscan (gadoteric acid), a new macrocyclic MRI contrast agent, in Europe, and in July 2021 in South Korea.
What else is in the report?
Future market insights offers a unique perspective and actionable insights on the magnetic resonance imaging contrast agents market in its latest study, presenting historical demand assessment from 2014–2021 and projections for 2022–2029, based on product type (paramagnetic contrast agents and superparamagnetic contrast agents) and end user (hospitals, ambulatory surgical centers, and diagnostic centers) across seven key regions.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-11023
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Brain Imaging And Neuroimaging Market – Over the last few years, the healthcare industry has been witnessing technological advances in medical devices which offer robust services to cater to patients who are suffering from brain related diseases.
Preclinical Imaging Market – Preclinical Imaging is used for imagining of living animals specifically for research purposes, research can be for drug development and other types. Imaging products are very important so as to observe the changes in organs, cell or a tissue these changes are observed in animals that respond to environmental changes or physiological changes.
Intravascular Imaging Market – Intravascular imaging allows healthcare professionals to examine the inner structure and changes in the internal lining of the blood vessels. There are various uses of the intravascular imaging techniques and are used for different applications.
Small Animal Imaging (In Vivo) Market – Small animal imaging (In vivo) is a technique used for imaging biological processes in living animals which shows the changes in cellular activity to study the effect of drugs and disease progression.
Medical Imaging Software Market – The medical imaging software market is growing with increase in demand for technically advanced market for imaging devices. Rapid technological innovations has derived a lot of changes in clinical diagnosis, treatment and disease monitoring.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com